{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:11:52Z","timestamp":1785222712152,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS) and epileptic encephalopathy with spike wave activation in sleep (EE-SWAS) are rare but well-known childhood epileptic disorders. Steroids are one of the first line treatment options, but a variety of steroid regimens exists. The aim of this survey was to evaluate the practices of steroid therapy in the treatment of (D)EE-SWAS across European centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>An online survey was conducted (via \u2018SurveyMonkey\u2019 Europe) among European epilepsy centers. Questions asked included: characteristics of replying center, applied definition of DEE-SWAS, existence of regional\/national guidelines regarding diagnostic and therapeutic management. Particular attention was paid to the indication\/contraindication of steroids and treatment regimens used.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Responses were obtained from 60 centers across 18 countries. Only 15% of centers reported the availability of national guidelines for the management of (D)EE-SWAS. There were variations in definition of (D)EE-SWAS, with Spike-Wave- Index (SWI)\u2009&gt;\u200985 (irrespective of cognitive status) and SWI\u2009&gt;\u200950% with concurrent neurodevelopmental regression being the most prevalent, reported in 36% and 50%, respectively. Steroids and clobazam were considered the predominant treatment options, with the primary indication for steroids being neurodevelopmental arrest (52%) and failure of clobazam treatment (51%). Treatment goals of steroid treatment primarily focused on neurodevelopmental improvement (95%), and reduction of SWI (66%). Methylprednisolone and prednisone were the most frequently used steroids, although other steroid types were also reported. Pulse therapy was utilized exclusively in 47% of centers. The most commonly used steroid regimen was intravenous\/oral methylprednisolone pulse therapy (20\u00a0mg\/kg\/day for 3 days, either monthly or weekly), although a broad variety of different regimens were reported. Criteria influencing decisions about steroid treatment were largely based on personal experience, with scientific publications playing a role in decision-making in only 14% of centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Steroids are part of the first line therapy of (D)EE-SWAS across Europe, but heterogeneity in formulations, dosages, and regimens persists due to limited guideline availability. The absence of comparative studies and the discordant definitions of (D)EE-SWAS further hinder comparisons of treatment efficacy. We recommend that harmonizing steroid treatment strategies is imperative for optimizing (D)EE-SWAS management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03725-0","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:07:31Z","timestamp":1745917651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["European experience of steroid therapy in children with developmental and epileptic encephalopathy with spike wave activation in sleep ((D)EE-SWAS)"],"prefix":"10.1186","volume":"20","author":[{"given":"Dilan","family":"Canbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor E.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sch\u00f6nberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"San Antonio-Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-5384","authenticated-orcid":false,"given":"Kerstin Alexandra","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"6","key":"3725_CR1","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.17241","volume":"63","author":"N Specchio","year":"2022","unstructured":"Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022;63(6):1398\u2013442.","journal-title":"Epilepsia"},{"issue":"11","key":"3725_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/epi.13128","volume":"56","author":"B van den Munckhof","year":"2015","unstructured":"van den Munckhof B, van Dee V, Sagi L, Caraballo RH, Veggiotti P, Liukkonen E, et al. Treatment of electrical status epilepticus in sleep: A pooled analysis of 575 cases. Epilepsia. 2015;56(11):1738\u201346.","journal-title":"Epilepsia"},{"key":"3725_CR3","unstructured":"Tassinari C, Terzano G, Capocchi G, Dalla Bernardina B, Vigevano F, Daniele O et al. Epileptic seizures during sleep in children. New York. 1977;345\u2013354. In Penry JK, editor Epilepsy. The 8th international symposium."},{"issue":"2","key":"3725_CR4","first-page":"154","volume":"28","author":"T Loddenkemper","year":"2011","unstructured":"Loddenkemper T, Fern\u00e1ndez IS, Peters JM. Continuous Spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc. 2011;28(2):154\u201364.","journal-title":"J Clin Neurophysiol Off Publ Am Electroencephalogr Soc"},{"issue":"4","key":"3725_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/epi.12039","volume":"54","author":"IS Fern\u00e1ndez","year":"2013","unstructured":"Fern\u00e1ndez IS, Chapman KE, Peters JM, Kothare SV, Nordli DR, Jensen FE, et al. The tower of babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013;54(4):741\u201350.","journal-title":"Epilepsia"},{"issue":"7","key":"3725_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/epi.12678","volume":"55","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2014","unstructured":"S\u00e1nchez Fern\u00e1ndez I, Chapman K, Peters JM, Klehm J, Jackson MC, Berg AT, et al. Treatment for continuous spikes and waves during sleep (CSWS): survey on treatment choices in North America. Epilepsia. 2014;55(7):1099\u2013108.","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"3725_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eplepsyres.2013.02.010","volume":"105","author":"RH Caraballo","year":"2013","unstructured":"Caraballo RH, Veggiotti P, Kaltenmeier MC, Piazza E, Gamboni B, Lopez Avaria MF, et al. Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients. Epilepsy Res. 2013;105(1\u20132):164\u201373.","journal-title":"Epilepsy Res"},{"issue":"S1","key":"3725_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1684\/epd.2019.1061","volume":"21","author":"FE Jansen","year":"2019","unstructured":"Jansen FE, Nikanorova M, Peltola M. Current treatment options for encephalopathy related to status epilepticus during slow sleep. Epileptic Disord. 2019;21(S1):76\u201381.","journal-title":"Epileptic Disord"},{"issue":"2","key":"3725_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1474-4422(23)00409-X","volume":"23","author":"MML van Arnhem","year":"2024","unstructured":"van Arnhem MML, van den Munckhof B, Arzimanoglou A, Perucca E, Mets\u00e4honkala L, Rubboli G, et al. Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial. Lancet Neurol. 2024;23(2):147\u201356.","journal-title":"Lancet Neurol"},{"key":"3725_CR10","doi-asserted-by":"publisher","first-page":"1142253","DOI":"10.3389\/fneur.2023.1142253","volume":"14","author":"LL Becker","year":"2023","unstructured":"Becker LL, Kaindl AM. Corticosteroids in childhood epilepsies: A systematic review. Front Neurol. 2023;14:1142253.","journal-title":"Front Neurol"},{"issue":"1","key":"3725_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1186\/s13063-020-04874-2","volume":"21","author":"B van den Munckhof","year":"2020","unstructured":"van den Munckhof B, Arzimanoglou A, Perucca E, van Teeseling HC, Leijten FSS, Braun KPJ, et al. Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*). Trials. 2020;21(1):957.","journal-title":"Trials"},{"issue":"6","key":"3725_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0034-1387817","volume":"45","author":"T Bast","year":"2014","unstructured":"Bast T, Richter S, Ebinger F, Rating D, Wiemer-Kruel A, Schubert-Bast S. Efficacy and tolerability of Methylprednisolone pulse therapy in childhood epilepsies other than infantile spasms. Neuropediatrics. 2014;45(6):378\u201385.","journal-title":"Neuropediatrics"},{"issue":"1","key":"3725_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2004.06.020","volume":"32","author":"C Okuyaz","year":"2005","unstructured":"Okuyaz C, Aydin K, G\u00fcc\u00fcyener K, Serdaro\u011flu A. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol. 2005;32(1):64\u20137.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"3725_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pediatrneurol.2004.12.006","volume":"32","author":"DB Sinclair","year":"2005","unstructured":"Sinclair DB, Snyder TJ. Corticosteroids for the treatment of Landau-kleffner syndrome and continuous spike-wave discharge during sleep. Pediatr Neurol. 2005;32(5):300\u20136.","journal-title":"Pediatr Neurol"},{"issue":"Suppl 7","key":"3725_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1528-1167.2009.02224.x","volume":"50","author":"M Buzatu","year":"2009","unstructured":"Buzatu M, Bulteau C, Altuzarra C, Dulac O, Van Bogaert P. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia. 2009;50(Suppl 7):68\u201372.","journal-title":"Epilepsia"},{"key":"3725_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2019.02.016","volume":"94","author":"A Hempel","year":"2019","unstructured":"Hempel A, Frost M, Agarwal N. Language and behavioral outcomes of treatment with pulse-dose prednisone for electrical status epilepticus in sleep (ESES). Epilepsy Behav EB. 2019;94:93\u20139.","journal-title":"Epilepsy Behav EB"},{"issue":"5","key":"3725_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.braindev.2005.09.004","volume":"28","author":"M Inutsuka","year":"2006","unstructured":"Inutsuka M, Kobayashi K, Oka M, Hattori J, Ohtsuka Y. Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev. 2006;28(5):281\u20136.","journal-title":"Brain Dev"},{"issue":"6","key":"3725_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.seizure.2005.07.002","volume":"14","author":"H Verhelst","year":"2005","unstructured":"Verhelst H, Boon P, Buyse G, Ceulemans B, D\u2019Hooghe M, Meirleir LD, et al. Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure. 2005;14(6):412\u201321.","journal-title":"Seizure"},{"key":"3725_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.yebeh.2017.06.019","volume":"74","author":"A Altunel","year":"2017","unstructured":"Altunel A, Altunel E\u00d6, Sever A. Response to adrenocorticotropic in attention deficit hyperactivity disorder-like symptoms in electrical status epilepticus in sleep syndrome is related to electroencephalographic improvement: A retrospective study. Epilepsy Behav EB. 2017;74:161\u20136.","journal-title":"Epilepsy Behav EB"},{"key":"3725_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2015.10.003","volume":"55","author":"J Chen","year":"2016","unstructured":"Chen J, Cai F, Jiang L, Hu Y, Feng C. A prospective study of dexamethasone therapy in refractory epileptic encephalopathy with continuous spike-and-wave during sleep. Epilepsy Behav EB. 2016;55:1\u20135.","journal-title":"Epilepsy Behav EB"},{"key":"3725_CR21","doi-asserted-by":"publisher","first-page":"107278","DOI":"10.1016\/j.eplepsyres.2023.107278","volume":"199","author":"KE Chapman","year":"2024","unstructured":"Chapman KE, Haubenberger D, Jen E, Tishchenko A, Nguyen T, McMicken C. Unmet needs in epileptic encephalopathy with spike-and-wave activation in sleep: A systematic review. Epilepsy Res. 2024;199:107278.","journal-title":"Epilepsy Res"},{"issue":"Suppl 7","key":"3725_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1528-1167.2009.02211.x","volume":"50","author":"M Scheltens-de Boer","year":"2009","unstructured":"Scheltens-de Boer M. Guidelines for EEG in encephalopathy related to ESES\/CSWS in children. Epilepsia. 2009;50(Suppl 7):13\u20137.","journal-title":"Epilepsia"},{"key":"3725_CR23","doi-asserted-by":"publisher","first-page":"109105","DOI":"10.1016\/j.yebeh.2023.109105","volume":"140","author":"G Rubboli","year":"2023","unstructured":"Rubboli G, Gardella E, Cantalupo G, Alberto Tassinari C. Encephalopathy related to status epilepticus during slow sleep (ESES). Pathophysiological insights and nosological considerations. Epilepsy Behav EB. 2023;140:109105.","journal-title":"Epilepsy Behav EB"},{"key":"3725_CR24","doi-asserted-by":"crossref","unstructured":"Papadopoulou MT, Muccioli L, Bisulli F, Klotz KA, Fons C, Trivisano M et al. Accessibility, availability and common practices regarding genetic testing for epilepsy across Europe: A survey of the European Reference Network EpiCARE. Epilepsia Open. 2024.","DOI":"10.1002\/epi4.12930"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03725-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03725-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03725-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:07:35Z","timestamp":1745917655000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03725-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3725"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03725-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This survey was approved by the Ethics Committee of the Albert-Ludwigs-University Freiburg, Germany (21-1508).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}